Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study

BACKGROUND: Poor adherence to the disease-modifying therapies (DMTs) for multiple sclerosis (MS) may attenuate clinical benefit. A better understanding of characteristics associated with non-adherence could improve outcomes. OBJECTIVE: To evaluate characteristics associated with non-adherence to inj...

Descripción completa

Detalles Bibliográficos
Autores principales: McKay, Kyla A, Tremlett, Helen, Patten, Scott B, Fisk, John D, Evans, Charity, Fiest, Kirsten, Campbell, Trudy, Marrie, Ruth Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407504/
https://www.ncbi.nlm.nih.gov/pubmed/27357507
http://dx.doi.org/10.1177/1352458516657440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407504/
https://www.ncbi.nlm.nih.gov/pubmed/27357507
http://dx.doi.org/10.1177/1352458516657440

Ejemplares similares